Home
Supported by an independent educational grant from AbbVie Inc. Join Drs Camidge and Dagogo-Jack in Chicago as they discuss the latest information on MET-altered NSCLC. In this lively symposium, our expert faculty will explore the role of ADCs in the management of NSCLC, with a focus on cMET targeted agents. They will also cover MET-related activity as it relates to NSCLC and new therapeutic agents on the horizon. You don’ t want to miss this exciting opportunity to interact with the experts! Register Now